What does BioMarin Pharmaceutical, Inc. do?

Jun 22 2025 06:39 PM IST
share
Share Via
BioMarin Pharmaceutical, Inc. is a biotechnology company that develops and commercializes pharmaceuticals for various diseases. As of March 2025, it reported net sales of $733 million and a market cap of approximately $10.55 billion.
Overview:
BioMarin Pharmaceutical, Inc. is a biotechnology company that develops and commercializes pharmaceuticals for various diseases and medical conditions, operating within the Pharmaceuticals & Biotechnology industry and classified as a mid-cap company.

Financial Snapshot:
Most recent Net Sales: 733 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 186 Million (Quarterly Results - Mar 2025)
Market cap: USD 10,547.66 Million (Mid Cap)

Key Metrics:
P/E: 20.00
Dividend Yield: 0.00%
Debt Equity: -0.11
Return on Equity: 9.49%
Price to Book: 1.82

Contact Details:
Address: 105 Digital Dr, NOVATO CA: 94949-8703
Tel: 1 415 5066700
Fax: 1 415 3827889
Website: http://www.bmrn.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News